Cargando…

Alignment of European Regulatory and Health Technology Assessments: A Review of Licensed Products for Alzheimer's Disease

Aims: To facilitate regulatory learning, we evaluated similarities and differences in evidence requirements between regulatory and health technology assessment (HTA) bodies of Alzheimer's disease (AD) approved products. Methods: The European marketing authorisation application dossiers and Euro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dekker, Marieke J. H. J., Bouvy, Jacoline C., O'Rourke, Diana, Thompson, Robin, Makady, Amr, Jonsson, Pall, Gispen-de Wied, Christine C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515927/ https://www.ncbi.nlm.nih.gov/pubmed/31134200 http://dx.doi.org/10.3389/fmed.2019.00073

Ejemplares similares

Regulatory and Health Technology Assessment Considerations for Disease-Modifying Drugs in Alzheimer’s Disease
por: Bouvy, Jacoline C., et al.
Publicado: (2018)

The Sandbox Approach and its Potential for Use in Health Technology Assessment: A Literature Review
por: Leckenby, Emily, et al.
Publicado: (2021)

Common Problems, Common Data Model Solutions: Evidence Generation for Health Technology Assessment
por: Kent, Seamus, et al.
Publicado: (2020)

Regulatory scientific advice in drug development: does company size make a difference?
por: Putzeist, Michelle, et al.
Publicado: (2010)

Sex Proportionality in Pre-clinical and Clinical Trials: An Evaluation of 22 Marketing Authorization Application Dossiers Submitted to the European Medicines Agency
por: Dekker, Marieke J. H. J., et al.
Publicado: (2021)

All-Male Panels and Gender Diversity of Issue Panels and Plenary Sessions at ISPOR Europe
por: Bouvy, Jacoline C., et al.
Publicado: (2019)

Challenges for Optimizing Real-World Evidence in Alzheimer’s Disease: The ROADMAP Project
por: Gallacher, John, et al.
Publicado: (2019)

Minimum United States Medical Licensing Examination and Comprehensive Osteopathic Medical Licensing Examination Scores Often Do Not Align
por: Nikolla, Dhimitri A, et al.
Publicado: (2023)

Requirements for generic anti-epileptic medicines: a regulatory perspective
por: Maliepaard, Marc, et al.
Publicado: (2009)

Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies
por: Makady, Amr, et al.
Publicado: (2017)

Regulatory Pathway for Licensing Biotherapeutics in Mexico
por: López-Morales, Carlos A., et al.
Publicado: (2018)

Oncologic orphan drugs approved in the EU – do clinical trial data correspond with real-world effectiveness?
por: Schuller, Yvonne, et al.
Publicado: (2018)

Repurposing Licensed Drugs for Use Against Alzheimer’s Disease
por: Norins, Leslie C.
Publicado: (2021)

Regulatory Scientific Advice on Non-Inferiority Drug Trials
por: Wangge, Grace, et al.
Publicado: (2013)

Managed Entry Agreements for Pharmaceuticals in the Context of Adaptive Pathways in Europe
por: Bouvy, Jacoline C., et al.
Publicado: (2018)

TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases
por: Annemans, Lieven, et al.
Publicado: (2020)

Run‐in periods and clinical outcomes of antipsychotics in dementia: A meta‐epidemiological study of placebo‐controlled trials
por: Hulshof, Tessa A., et al.
Publicado: (2019)

Factors Contributing to the Efficacy-Effectiveness Gap in the Case of Orphan Drugs for Metabolic Diseases
por: Schuller, Y., et al.
Publicado: (2017)

Future of the drug label: Perspectives from a multistakeholder dialogue
por: Gispen‐de Wied, Christine C., et al.
Publicado: (2019)

Fraudulent Licenses
por: Nolan, C. T.
Publicado: (1916)

Epidemiology of Adverse Drug Reactions in Europe: A Review of Recent Observational Studies
por: Bouvy, Jacoline C., et al.
Publicado: (2015)

Training and competency assessment of Clinical Embryologists and licensing of the profession in European countries
por: Scarica, Catello, et al.
Publicado: (2023)

Baseline imbalances and clinical outcomes of atypical antipsychotics in dementia: A meta‐epidemiological study of randomized trials
por: Hulshof, Tessa A., et al.
Publicado: (2018)

Licensed Homes for Inebriates
por: Temple, Beatrice B., et al.
Publicado: (1913)

Reimbursement of licensed cell and gene therapies across the major European healthcare markets
por: Jørgensen, Jesper, et al.
Publicado: (2015)

Dose‐Finding Studies Among Orphan Drugs Approved in the EU: A Retrospective Analysis
por: Schuller, Yvonne, et al.
Publicado: (2018)

The Use of Remote Monitoring Technologies: A Review of Recent Regulatory Scientific Advices, Qualification Opinions, and Qualification Advices Issued by the European Medicines Agency
por: Dekker, Marieke J. H. J., et al.
Publicado: (2021)

Child/Adolescent development and autonomous vehicle operation: “operator’s licenses” instead of driver’s licenses
por: Schwebel, David C
Publicado: (2018)

Licensing of Generic Medicines: Are There Any Challenges Left? A Pharmaceutical Regulatory Perspective
por: Borg, John Joseph, et al.
Publicado: (2014)

License to glue
por: Wells, William A.
Publicado: (2004)

Franchising & Licensing
por: SHERMAN, Andrew
Publicado: (2011)

Literature and License
Publicado: (1921)

Liquor License
Publicado: (1858)

Liquor License
Publicado: (1876)

Teaching and Licensing
Publicado: (1880)

Retention of provisionally licensed international medical graduates: a historical cohort study of general and family physicians in Newfoundland and Labrador
por: Mathews, Maria, et al.
Publicado: (2008)

Licensed Anti-Microbial Drugs Logical for Clinical Trials against Pathogens Currently Suspected in Alzheimer’s Disease
por: Norins, Leslie C.
Publicado: (2021)

A License to Practice Medicine Cannot Be a License to Harm
por: Schluger, Neil W., et al.
Publicado: (2022)

Drug development for exceptionally rare metabolic diseases: challenging but not impossible
por: Putzeist, Michelle, et al.
Publicado: (2013)

DNA replication origins retain mobile licensing proteins
por: Sánchez, Humberto, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cfpp90um43sou9ep6vlupm4dfo